α-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy
暂无分享,去创建一个
Fred H. Gage | Tobias Bäuerle | Arif B. Ekici | Jürgen Winkler | André Reis | Clarissa Gillmann | Michael Wegner | Christian Büttner | Markus J. Riemenschneider | Bilal E. Kerman | F. Gage | E. Masliah | A. Ekici | M. Wegner | J. Winkler | M. Riemenschneider | A. Reis | J. Schlachetzki | C. Gillmann | T. Bäuerle | Simone Reiprich | Eliezer Masliah | Johannes C. M. Schlachetzki | E. Valera | Benjamin Ettle | C. Büttner | B. Ettle | Simone Reiprich | Elvira Valera | B. Kerman | Christian Büttner | Elvira Valera
[1] D. S. Babu. Multiple-system atrophy. , 2015, The New England journal of medicine.
[2] J. Trojanowski,et al. Mouse Model of Multiple System Atrophy α-Synuclein Expression in Oligodendrocytes Causes Glial and Neuronal Degeneration , 2005, Neuron.
[3] P. Vanderhaeghen,et al. Generation of cortical neurons from mouse embryonic stem cells , 2009, Nature Protocols.
[4] K. Nave,et al. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. , 1998, Science.
[5] P. Mcgeer,et al. Myelin degeneration in multiple system atrophy detected by unique antibodies. , 1998, The American journal of pathology.
[6] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[7] G H Sato,et al. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[8] E. Masliah,et al. Intracellular alpha-synuclein affects early maturation of primary oligodendrocyte progenitor cells , 2014, Molecular and Cellular Neuroscience.
[9] P. Højrup,et al. p25α Relocalizes in Oligodendroglia from Myelin to Cytoplasmic Inclusions in Multiple System Atrophy , 2007 .
[10] C. Haass,et al. Physiology and Pathophysiology of α‐Synuclein: Cell Culture and Transgenic Animal Models Based on a Parkinson's Disease‐associated Protein , 2000, Annals of the New York Academy of Sciences.
[11] K. Irvine,et al. Remyelination protects axons from demyelination-associated axon degeneration. , 2008, Brain : a journal of neurology.
[12] F. Gage,et al. A regenerative approach to the treatment of multiple sclerosis , 2013, Nature.
[13] G. Wenning,et al. Interventional trials in atypical parkinsonism. , 2016, Parkinsonism & related disorders.
[14] K. Jellinger,et al. Towards translational therapies for multiple system atrophy , 2014, Progress in Neurobiology.
[15] Samuel Bernard,et al. Dynamics of Oligodendrocyte Generation and Myelination in the Human Brain , 2014, Cell.
[16] Timothy Edward John Behrens,et al. Training induces changes in white matter architecture , 2009, Nature Neuroscience.
[17] V. Friedrich,et al. Myelin basic protein gene contains separate enhancers for oligodendrocyte and Schwann cell expression , 1992, The Journal of cell biology.
[18] Jeff H. Duyn,et al. The contribution of myelin to magnetic susceptibility-weighted contrasts in high-field MRI of the brain , 2012, NeuroImage.
[19] Pierre J. Magistretti,et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration , 2012, Nature.
[20] J. Jankovic,et al. Natural History of Multiple System Atrophy in North America: A Prospective Cohort Study , 2015, The Lancet Neurology.
[21] Peter L. Lantos,et al. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome) , 1989, Journal of the Neurological Sciences.
[22] K. Jellinger,et al. Multiple system atrophy: A primary oligodendrogliopathy , 2008, Annals of neurology.
[23] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[24] Klaus-Armin Nave,et al. Oligodendrocytes: Myelination and Axonal Support. , 2015, Cold Spring Harbor perspectives in biology.
[25] P. Sørensen,et al. Erratum: Remyelination is extensive in a subset of multiple sclerosis patients (Brain (2006) 129, PART 12, (3165-3172) DOI: 10.1093/brain/awl217) , 2007 .
[26] Paul Theodor Pyl,et al. HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.
[27] J. Frisén,et al. Alpha-Synuclein Expression in the Oligodendrocyte Lineage: an In Vitro and In Vivo Study Using Rodent and Human Models , 2015, Stem cell reports.
[28] A. Lees,et al. Alpha-synuclein mRNA expression in oligodendrocytes in MSA , 2014, Glia.
[29] P. Højrup,et al. p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy. , 2007, The American journal of pathology.
[30] E. Masliah,et al. α-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy , 2014, Neurobiology of Aging.
[31] William D. Richardson,et al. Motor skill learning requires active central myelination , 2014, Science.
[32] S. Waxman,et al. Slowly Progressive Axonal Degeneration in a Rat Model of Chronic, Nonimmune-Mediated Demyelination , 2010, Journal of neuropathology and experimental neurology.
[33] R. Franklin,et al. Repair of demyelinated lesions by transplantation of purified 0-2A progenitor cells , 1993, Nature.
[34] Makoto Hashimoto,et al. Neurological and Neurodegenerative Alterations in a Transgenic Mouse Model Expressing Human α-Synuclein under Oligodendrocyte Promoter: Implications for Multiple System Atrophy , 2005, The Journal of Neuroscience.
[35] R. Takahashi,et al. Selective Nuclear Shrinkage of Oligodendrocytes Lacking Glial Cytoplasmic Inclusions in Multiple System Atrophy: A 3-Dimensional Volumetric Study , 2009, Journal of neuropathology and experimental neurology.
[36] Christopher W Mount,et al. Neuronal Activity Promotes Oligodendrogenesis and Adaptive Myelination in the Mammalian Brain , 2014, Science.
[37] T. Révész,et al. Identification and Quantification of Oligodendrocyte Precursor Cells in Multiple System Atrophy, Progressive Supranuclear Palsy and Parkinson's Disease , 2013, Brain pathology.
[38] J. Holton,et al. The neuropathology, pathophysiology and genetics of multiple system atrophy , 2012, Neuropathology and applied neurobiology.
[39] S. Gilman,et al. Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial , 2014, The Lancet Neurology.
[40] Fred H. Gage,et al. In vitro myelin formation using embryonic stem cells , 2015, Development.
[41] W. Poewe,et al. Placebo‐controlled trial of riluzole in multiple system atrophy , 2006, European journal of neurology.
[42] D. Attwell,et al. Oligodendrocyte Dynamics in the Healthy Adult CNS: Evidence for Myelin Remodeling , 2013, Neuron.
[43] Y. Sohn,et al. A randomized trial of mesenchymal stem cells in multiple system atrophy , 2012, Annals of neurology.
[44] P Sandroni,et al. Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.
[45] Sonja W. Scholz,et al. SNCA variants are associated with increased risk for multiple system atrophy , 2009, Annals of neurology.
[46] B. Pakkenberg,et al. Changes in total cell numbers of the basal ganglia in patients with multiple system atrophy — A stereological study , 2015, Neurobiology of Disease.
[47] Israel Steinfeld,et al. BMC Bioinformatics BioMed Central , 2008 .
[48] Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders? , 2015, Molecular Neurobiology.
[49] Alexander Gerhard,et al. Minocycline 1‐year therapy in multiple‐system‐atrophy: Effect on clinical symptoms and [11C] (R)‐PK11195 PET (MEMSA‐trial) , 2010, Movement disorders : official journal of the Movement Disorder Society.
[50] J. Trojanowski,et al. α‐synuclein is developmentally expressed in cultured rat brain oligodendrocytes , 2000, Journal of neuroscience research.
[51] F. Gage,et al. Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. , 2008, Cell stem cell.
[52] G. Wenning,et al. Multiple system atrophy. , 2013, Handbook of clinical neurology.
[53] W. Poewe,et al. Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy , 2012, Acta Neuropathologica.
[54] Christopher Lawrence. Degeneration , 2010, The Lancet.
[55] Hans Lassmann,et al. Remyelination is extensive in a subset of multiple sclerosis patients. , 2006, Brain : a journal of neurology.
[56] Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy , 2014, Acta neuropathologica communications.
[57] E. Masliah,et al. Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy , 2015, Molecular Neurodegeneration.
[58] G. Halliday,et al. Increased expression of ABCA8 in multiple system atrophy brain is associated with changes in pathogenic proteins. , 2013, Journal of Parkinson's disease.